Phosphomannose isomerase (PMI) deficiency is the cause of a new type of carbohydrate-deficient glycoprotein syndrome (CDGS). The disorder is caused by mutations in the PMI1 gene. The clinical phenotype is characterized by protein-losing enteropathy, while neurological manifestations prevailing in other types of CDGS are absent. Using standard diagnostic procedures, the disorder is indistinguishable from CDGS type Ia (phosphomannomutase deficiency). Daily oral mannose administration is a successful therapy for this new type of CDG syndrome classified as CDGS type Ib.
R Niehues, M Hasilik, G Alton, C Körner, M Schiebe-Sukumar, H G Koch, K P Zimmer, R Wu, E Harms, K Reiter, K von Figura, H H Freeze, H K Harms, T Marquardt
Title and authors | Publication | Year |
---|---|---|
Using heparin therapy to reverse protein-losing enteropathy in a patient with CDG-Ib
YS Liem, L Bode, HH Freeze, FW Leebeek, AA Zandbergen, JH Wilson |
Nature Clinical Practice Gastroenterology & Hepatology | 2008 |
Long-standing mild hypertransaminasaemia caused by congenital disorder of glycosylation (CDG) type IIx
PL Calvo, S Pagliardini, M Baldi, A Pucci, L Sturiale, D Garozzo, T Vinciguerra, C Barbera, J Jaeken |
Journal of Inherited Metabolic Disease | 2008 |
Dolichol-phosphate mannose synthase: Structure, function and regulation
Y Maeda, T Kinoshita |
Biochimica et Biophysica Acta (BBA) - General Subjects | 2008 |
Development of liver disease despite mannose treatment in two patients with CDG-Ib
K Mention, F Lacaille, V Valayannopoulos, S Romano, A Kuster, M Cretz, H Zaidan, L Galmiche, F Jaubert, Y Keyzer, N Seta, P Lonlay |
Molecular Genetics and Metabolism | 2008 |
Impact of glycans on T-cell tolerance to glycosylated self-antigens
AW Purcell, IR van Driel, PA Gleeson |
Immunology and Cell Biology | 2008 |
A "Glyconutrient Sham"
RL Schnaar, HH Freeze |
Glycobiology | 2008 |
Evaluation of protein safety in the context of agricultural biotechnology
B Delaney, J Astwood, H Cunny, R Conn, C Herouetguicheney, S Macintosh, L Meyer, L Privalle, Y Gao, J Mattsson |
Food and Chemical Toxicology | 2008 |
Anomalies congénitales de glycosylation des glycoprotéines sériques
P Lonlay, N Seta |
EMC - Pédiatrie - Maladies infectieuses | 2008 |
Anomalies congénitales de glycosylation
P Lonlay, V Valayannopoulos, T Dupré, S Vuillaumier-Barrot, N Seta |
Archives de Pédiatrie | 2008 |
Defecto congénito de glucosilación tipo Ib. Experiencia en el tratamiento con manosa
EM Hernández, AI Pajares, BP González, MJ Crespo, FL Pérez, JM López-Manzanares, MU Pérez, CP Silvestre |
Anales de Pediatría | 2008 |
RECURRENT THROMBO-EMBOLISM IN A CHILD WITH A CONGENITAL DISORDER OF GLYCOSYLATION (CDG) TYPE IB AND TREATMENT WITH MANNOSE
RY Tamminga, DJ Lefeber, WA Kamps, FJ van Spronsen |
Pediatric Hematology-Oncology | 2008 |
Mannose Inhibits Hyaluronan Synthesis by Down-regulation of the Cellular Pool of UDP- N -acetylhexosamines
TA Jokela, M Jauhiainen, S Auriola, M Kauhanen, R Tiihonen, MI Tammi, RH Tammi |
The Journal of biological chemistry | 2008 |
Screening Using Serum Percentage of Carbohydrate-Deficient Transferrin for Congenital Disorders of Glycosylation in Children with Suspected Metabolic Disease
C Pérez-Cerdá, D Quelhas, AI Vega, J Ecay, L Vilarinho, M Ugarte |
Clinical chemistry | 2008 |
Glycoscience
BO Fraser-Reid, K Tatsuta, J Thiem |
2008 | |
Laboratory Guide to the Methods in Biochemical Genetics
N Blau, M Duran, KM Gibson |
2008 |